HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mediastinoscope-assisted transhiatal esophagectomy for esophageal cancer.

AbstractBACKGROUND:
Transthoracic esophagectomy (TTE) is a radical strategy for treatment of esophageal cancer, and the morbidity and mortality are high. Transhiatal esophagectomy (THE) is advantageous because it avoids thoracotomy and has a shorter surgical time, but risk of intraoperative morbidity stresses the surgeon and lymph node sampling is not possible.
METHODS:
Mediastinoscope-assisted transhiatal esophagectomy (MATHE) was performed in 42 patients with esophageal cancer. Patients with superficial esophageal cancer and medical risk were included. Feasibility and efficacy of this procedure are discussed by examining short- and long-term morbidity, mortality, and survival.
RESULTS:
With the mediastinoscope, esophagectomy was performed safely under direct vision. There was only a small amount of bleeding, and surgical time was short. Little morbidity and no deaths were recorded.
CONCLUSION:
MATHE is a safe and minimally invasive technique that allows direct visualization of mediastinal structures Lymph node sampling was feasible because of clear visualization of the mediastinum.
AuthorsA Tangoku, S Yoshino, T Abe, H Hayashi, T Satou, T Ueno, M Oka
JournalSurgical endoscopy (Surg Endosc) Vol. 18 Issue 3 Pg. 383-9 (Mar 2004) ISSN: 1432-2218 [Electronic] Germany
PMID14735343 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adenocarcinoma (mortality, pathology, surgery)
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Carcinoma, Squamous Cell (mortality, pathology, surgery)
  • Comorbidity
  • Diaphragm
  • Esophageal Neoplasms (mortality, pathology, surgery)
  • Esophagectomy (methods)
  • Feasibility Studies
  • Female
  • Humans
  • Lymph Nodes (pathology)
  • Lymphatic Metastasis
  • Male
  • Mediastinoscopy (methods)
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Neoplasm Invasiveness
  • Pneumonia, Aspiration (epidemiology)
  • Postoperative Complications (mortality)
  • Risk
  • Vocal Cord Paralysis (epidemiology, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: